Clinical Trial Search

Primary: Changes in Endocrine Disrupting Chemical (EDC) Levels as Measured by the Post-intervention Value Minus the Baseline Value. — 5.83; 18.43; 56.94; 75.30 ng/ml — p=<0.05

Primary: Luteinizing Hormone Pulse Amplitude — 2.73; 1.12 IU/L

Primary: Log Signal Intensity of Bisphenol A (BPA) in Child Urine Samples — 0.00; 5.43 Log(Arbitrary Units)

Primary: Plasma DCA (Microgram/ml) After 5 Days of Therapeutic Level Chloral Hydrate on Arm 2A. — 1.64 micrograms/ml

Primary: Change in Internal Dose of Urinary Phthalate Metabolites — 1.9 percent change of sumLMW

Primary: Percent Change in BOLD Signal — -.43; .20 percentage of BOLD signal changes

Primary: Changes in Luteinizing Hormone (LH) Pulse Amplitude (Aim 1) — 4.1; 3.6 IU/L

Primary: Change in the Average LH Pulse Amplitude — -.04; .4 IU/L

Primary: Hypothesize That Subject's Genotype Will Determine How DCA is Metabolized. — 1592; 232 Minutes — p=0.023

Primary: Difference Between Peak Inhibin B — 100.8; 38.8 picograms/mL

Primary: Very-Low Density Lipoprotein-Triglyceride (VLDL-TG) Secretion Rate — 3.13; 2.03; 4.66; 3.36 umol/min/L plasma — p=0.85

Primary: Percent Change From Baseline for Total PCB Levels — 92; 96 % of baseline total PCBs

Primary: Resting Energy Expenditure (REE) — -37.8; -87.2; 14.6; -19.3 kcal/d — p=<0.05

Primary: Endothelial Progenitor Cells — 0.101; 0.081 percentage of all lymphocytes — p=0.28

Primary: FMD/Shear — 0.182; 0.206; 0.155; 0.219 %/s^-1

Primary: Change in Binge Eating Sum Score — -0.60; 0.89 score on a scale

Primary: Change in Lumbar Bone Mineral Density — 0.025; 0.008; 0.012 g/cm^2 — p=0.039

Primary: Matsuda Index- Whole Body Insulin Sensitivity Index — -1.02; -0.10; -1.45 units on a scale — p=0.27

Primary: Attentional Bias (Early Follicular Phase) — 347.99; 355.02 milliseconds

Primary: Weight — 91.3; 92.3; 88.6; 87.4 kilograms (kg)

Primary: Change in Weight From Baseline at 12 Months — 1.1; 1.9 kilograms